News

Filter

Current filters:

Riluzole

1 to 9 of 59 results

Trophos initiates pivotal efficacy study of ALS drug

06-05-2009

French drug developer Trophos SA has initiated a pivotal efficacy study of olesoxime in amyotrophic lateral…

NystatinOralRilutekRiluzole

Scientists discover why animal studies may lead to ineffective ALS drugs

28-01-2008

A five-year study of more than 70 drugs, many with reported survival benefit in a mouse model of the…

Aventis PharmaRilutekRiluzoleSanofi-Aventis

Trophos completes Ph Ib TRO19622 program

11-12-2006

Trophos, a French biopharmaceutical company specializing in the discovery and development of drugs for…

NystatinOralRilutekRiluzole

Pyhtopharm presents quarterly update on pipeline developments

01-05-2006

UK-based company Phytopharm, a specialist developer of pharmaceuticals based on plant extracts, has issued…

Aventis PharmaMerck KGaARilutekRiluzoleSanofi-AventisSchering PloughSchering-Plough

Impax comments on Rilutek generic ruling

06-09-2004

Impax Laboratories of the USA says that the District Court ofWilmington, Delaware, has ruled that Aventis…

Aventis PharmaRilutekRiluzole

ExonHit says ALS study is on track

24-02-2003

France's ExonHit Therapeutics has completed patient recruitment in aPhase II trial of its lead compound,…

Aventis PharmaPentoxifyllineRilutekRiluzoleTrental

1 to 9 of 59 results

Back to top